The somatostatin analog octreotide as potential treatment for re- stenosis and chronic rejection

Transplantation Proceedings

Volumn 29, Issue 6, 1997, Pages 2599-2600

  Weckbecker, G ^a   Pally, C ^a   Raulf, F ^a   Beckmann, N ^a   Schuurman, J H ^a   Rudin, M ^a   Bruns, C ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

ARTERY INTIMA PROLIFERATION; CONFERENCE PAPER; DRUG EFFECT; DRUG RECEPTOR BINDING; GRAFT OCCLUSION; HUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RESTENOSIS;

ANGIOPLASTY; ANIMALS; BLOOD VESSEL PROSTHESIS; CAROTID ARTERIES; CELL DIVISION; CELL MOVEMENT; GRAFT OCCLUSION, VASCULAR; HORMONES; OCTREOTIDE; RATS; TUNICA MEDIA; VASCULAR DISEASES;

EID: 0030868709     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(97)00523-X     Document Type: Conference Paper

References (10)

1. Weckbeckcr G, Raulf F, Stolz B. et al: Pharmacol Ther 60:245, 1993
2. Motomura N, Foegh ML: Transplant Immunol 4:99, 1996
3. Mennander A, Räisänen A, Paavonen T, et al: Transplantation 55:124, 1993
4. Akyürck ML, Larsson E, Funa K. et al: Transplant Proc 27:3555, 1995
5. Bruns C. Raulf F, Hoyer D, et al: Metabolism 45(suppl 1):1, 1996
6. Schuurman HJ, Weckbecker G, Bruns C, et al: Transplantation Proc 29:(this issue), 1997
7. Shaw LA, Rudin M, Cook NS: Trends Pharmacol Sci 16:401, 1995
8. Cook NS, Zerwes H-G, Pally C, et al: Cardiovasc Res 28:215, 1994
9. Schuurman HJ, Beckmann N, Briner U, et al: Transplant Proc 28:3272, 1996
10. Weekbecker G, Raulf F, Tolcsvai L, et al: Digestion 57(suppl 1):22, 1996